THE WOODLANDS, Texas, May 2, 2019 /PRNewswire-PRWeb/ -- Ted Courtemanche has joined Conversio Health as SVP of Client
Mr. Courtemanche brings a respected track record of success in high-growth healthcare services, population health and patient engagement businesses. He will lead Conversio Health's analytics, client management and implementation services as Conversio Health continues to address the challenges unique to living with and managing chronic health conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma.
Mr. Courtemanche previously served as SVP of Operations of Phytel (acquired by IBM) and Vice President of Medical Economics at Accordant Health Services (acquired by CVS/Caremark/AdvancePCS). He also founded a consulting practice providing services to emerging health care technology companies.
"Ted brings a wealth of experience in growing and operating high-growth healthcare companies, leveraging analytics to improve outcomes and demonstrate value as well as relevant industry knowledge in population management and patient engagement. We are excited to have Ted join our team."
About Conversio Health
Conversio Health is a healthcare services and pharmacy provider with extensive experience in managing and treating chronic respiratory conditions. Conversio works collaboratively in the delivery of care, in accordance with agreed upon medication adherence protocols. Conversio Health is a licensed pharmacy that services patients in over 45 states, with nationwide distribution.
Conversio Health is Joint Commission accredited and a member of Professional Compounding Centers of America (PCCA), the International Academy of Compounding Pharmacists (IACP), the American Association of Diabetes Educators (AADE) and the American Association for Respiratory Care (AARC).
For further information on Conversio Health visit http://www.conversiohealth.com.
SOURCE Conversio Health
Subscribe to our Free Newsletters!